| Cost-related insulin underuse among patients with diabetes D Herkert, P Vijayakumar, J Luo, JI Schwartz, TL Rabin, E DeFilippo, ... JAMA internal medicine 179 (1), 112-114, 2019 | 230 | 2019 |
| HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China L Wang, Z Ge, J Luo, D Shan, X Gao, G Ding, J Zhou, W He, N Wang JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 232, 2010 | 119 | 2010 |
| Coverage, formulary restrictions, and out-of-pocket costs for sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in the Medicare Part D program J Luo, R Feldman, SD Rothenberger, I Hernandez, WF Gellad JAMA Network Open 3 (10), e2020969-e2020969, 2020 | 87 | 2020 |
| Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US LA Eberly, L Yang, UR Essien, ND Eneanya, HM Julien, J Luo, AS Nathan, ... JAMA Health Forum 2 (12), e214182-e214182, 2021 | 82 | 2021 |
| Implementation of a health plan program for switching from analogue to human insulin and glycemic control among Medicare beneficiaries with type 2 diabetes J Luo, NF Khan, T Manetti, J Rose, A Kaloghlian, B Gadhe, SH Jain, ... JAMA 321 (4), 374-384, 2019 | 55 | 2019 |
| Trends in Medicaid reimbursements for insulin from 1991 through 2014 J Luo, J Avorn, AS Kesselheim JAMA internal medicine 175 (10), 1681-1687, 2015 | 53 | 2015 |
| The roles of labor migrants' wives in HIV/AIDS risk and prevention in Tajikistan A Golobof, S Weine, M Bahromov, J Luo aids Care 23 (1), 91-97, 2011 | 46 | 2011 |
| Variation in prescription drug prices by retail pharmacy type: a national cross-sectional study J Luo, M Kulldorff, A Sarpatwari, A Pawar, AS Kesselheim Annals of Internal Medicine 171 (9), 605-611, 2019 | 45 | 2019 |
| Potential gains in life expectancy associated with achieving treatment goals in US adults with type 2 diabetes H Kianmehr, P Zhang, J Luo, J Guo, ME Pavkov, KMK Bullard, EW Gregg, ... JAMA network open 5 (4), e227705-e227705, 2022 | 40 | 2022 |
| Strategies to improve the affordability of insulin in the USA J Luo, AS Kesselheim, J Greene, KJ Lipska The Lancet Diabetes & Endocrinology 5 (3), 158-159, 2017 | 39 | 2017 |
| Comparative effectiveness and safety of thalidomide and lenalidomide in patients with multiple myeloma in the United States of America: a population-based cohort study J Luo, JJ Gagne, J Landon, J Avorn, AS Kesselheim European Journal of Cancer 70, 22-33, 2017 | 37 | 2017 |
| Effect of generic competition on atorvastatin prescribing and patients’ out-of-pocket spending J Luo, JD Seeger, M Donneyong, JJ Gagne, J Avorn, AS Kesselheim JAMA Internal Medicine 176 (9), 1317-1323, 2016 | 36 | 2016 |
| Evolution of insulin patents and market exclusivities in the USA J Luo, AS Kesselheim The Lancet Diabetes & Endocrinology 3 (11), 835-837, 2015 | 32 | 2015 |
| Antiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004–2011 J Luo, MA Oliveira, MBC Ramos, A Maia, CGS Osorio-de-Castro BMC Public Health 14, 1-7, 2014 | 32 | 2014 |
| Diabetes in humanitarian crises: the Boston Declaration S Kehlenbrink, LM Jaacks, SA Perone, É Ansbro, E Ashbourne, ... The Lancet Diabetes & Endocrinology 7 (8), 590-592, 2019 | 27 | 2019 |
| Evaluation of out-of-pocket costs and treatment intensification with an SGLT2 inhibitor or GLP-1 RA in patients with type 2 diabetes and cardiovascular disease J Luo, R Feldman, KC Kim, S Rothenberger, M Korytkowski, I Hernandez, ... JAMA Network Open 6 (6), e2317886-e2317886, 2023 | 19 | 2023 |
| Origins of the crisis in insulin affordability and practical advice for clinicians on using human insulin J Luo, WF Gellad Current diabetes reports 20, 1-8, 2020 | 18 | 2020 |
| Rates and costs of dispensing naloxone to patients at high risk for opioid overdose in the United States, 2014–2018 RE Barenie, JJ Gagne, AS Kesselheim, A Pawar, A Tong, J Luo, ... Drug safety 43, 669-675, 2020 | 16 | 2020 |
| Does Powerlessness Explain Elevated HIV Risk Among Tajik Labor Migrants? An Ethnographic Study J Luo, S Weine, MS Mahbat Bahromov MD, A Golobof Journal of HIV/AIDS & Social Services 11 (2), 105-124, 2012 | 16 | 2012 |
| Insulin for all: treatment activism and the global diabetes crisis J Luo, G Gonsalves, J Greene The Lancet 393 (10186), 2116-2117, 2019 | 14 | 2019 |
Jerry AvornHarvard Medical School在 partners.org 的电子邮件经过验证
